Imatinib mesilate for the treatment of gastrointestinal stromal tumour. - Wikidata - wikimedia - TriplyDB

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

http://www.wikidata.org/entity/Q37142082

about

Evaluation of self-reported progression and correlation of imatinib dose to survival in patients with metastatic gastrointestinal stromal tumors: an open cohort study Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.Validation of analytic methods for biomarkers used in drug development Pharmacotherapy of sarcoma.KIT and platelet-derived growth factor receptor α gene expression in laryngeal small cell carcinoma.Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy.Gastrointestinal stromal tumors: treatment patterns of a population-based sample.

P2860

Q33756542-83A93DC4-5EB5-424D-A209-6243341BDB9D Q33821400-A46DA088-581B-41CA-A011-3B276F4BB03F Q37284255-8FE4D1C8-8645-440F-A85B-0616EA8D72EA Q37532566-E3C2DAE4-7DEB-4104-AEE9-7E400D7C22C9 Q37764098-822A436F-6F51-4F68-8147-921AE6EE94BF Q38030856-359547EA-05C8-4931-9BB9-B330AB4132BD Q39015373-390CFA44-6FA1-4A7A-A9F7-CE943769F0B2

P2860

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

http://www.wikidata.org/entity/Q37142082

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@en

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@nl

type

label

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@en

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@nl

prefLabel

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@en

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@nl

P1433

Q37142082-685020E6-6096-4CAA-98AA-6E0CB1EE16B4

P1476

Q37142082-BCCE441A-AF43-440D-9C25-1D5E26838BF9

P2093

Q37142082-06798ABA-CAEA-47E7-B7F6-663E2AD7CBC9

Q37142082-1A18338E-1245-4104-8C89-3D42E09A7D34

Q37142082-78ECF8A7-F2E8-4B58-B374-E953E6C63A75

Q37142082-7E1DB7D6-7AAD-4279-96EF-ECBD17B977C8

Q37142082-8A760D7B-AB09-47E5-BE91-2ED16010C50A

Q37142082-9E8E089F-B89A-442B-961E-EE3605826487

Q37142082-CAC8F8A3-530A-46CC-8A7F-63C2120244F2

Q37142082-EDA2425E-EBCD-43D8-8939-EBB3B59AC3C0

Q37142082-F14E763C-0359-4E32-91FA-B4ABDF907309

Q37142082-F3145862-E556-4F44-99BA-8006E1230D14

P2860

Q37142082-0302294E-F779-4269-919B-5E6CB8F7203C

Q37142082-03627FB6-D834-456D-8981-D70C4D1D1E15

Q37142082-0497EC9F-A51C-47AB-ADC4-617122C9756E

Q37142082-09BBC5BE-1F71-4DA0-9E07-917A5B5E1ADF

Q37142082-0CF0A65B-51B0-46A0-B752-03C15F1994B4

Q37142082-1898AC99-3191-4411-BD65-DAD4DBF22BFA

Q37142082-2106B3B0-6783-459A-9926-A5E45F2B3604

Q37142082-228EF33F-CBA6-46A4-A6B6-2873B36B7C2A

Q37142082-23221F90-6ADD-4C1C-8591-168DA3FCE7A7

Q37142082-2331963A-4AA5-4143-BA46-A9C2ADF931CC

P304

Q37142082-F752A779-1223-4829-9BA6-EB4209540F20

P31

Q37142082-EA8F3842-D301-4250-8DE8-12795314C27E

P356

Q37142082-5CBBD409-27DD-414C-82E1-C86BDE8A6DDF

P407

Q37142082-4B641D2F-5536-4614-B00F-1B45D7A18F4B

P433

Q37142082-0428315F-79B0-4C6E-AF3C-5E77AE81E8D2

P478

Q37142082-6B5718CC-8DCA-4EB7-8D3A-7494C71828B6

P50

Q37142082-39663EFB-32CA-4E09-9EB7-CB11070C23A0

Q37142082-B07A2088-18BA-4558-9E1E-0F3A042A657C

Q37142082-F556BA89-A1BA-4B59-8C02-DC824440907A

P577

Q37142082-71A14AD3-7620-402F-A1B2-A7FBF684BAEF

P698

Q37142082-F59828BF-133F-4B9D-83A9-04F2BF108C5A

P921

Q37142082-9C05E86A-4AA7-46E7-BE0F-54E39AD0C138

P356

14656566.9.7.1211

P1433

Expert Opinion on Pharmacotherapy

P1476

Imatinib mesilate for the treatment of gastrointestinal stromal tumour.

@en

P2093

Armelle Dufresne

http://www.w3.org/2001/XMLSchema#string

Dominique Ranchère

http://www.w3.org/2001/XMLSchema#string

Hiba El Sayadi

http://www.w3.org/2001/XMLSchema#string

Intidar Labidi

http://www.w3.org/2001/XMLSchema#string

Laurent Alberti

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Sunyach

http://www.w3.org/2001/XMLSchema#string

Philippe A Cassier

http://www.w3.org/2001/XMLSchema#string

Pierre Méeus

http://www.w3.org/2001/XMLSchema#string

Samia Arifi

http://www.w3.org/2001/XMLSchema#string

Séverine Tabone

http://www.w3.org/2001/XMLSchema#string

P2860

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

P304

1211-1222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.9.7.1211

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Ray-Coquard

Anne-Valérie Decouvelaere

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18422477

http://www.w3.org/2001/XMLSchema#string

P921

imatinib mesylate